课题基金 / 基金详情

Therapeutic Targeting of Human Prostate Cancer

Therapeutic Targeting of Human Prostate Cancer
人类前列腺癌的治疗靶向
批准号:
6838087
负责人:
ANNE E CRESS
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2005-04-30

项目摘要

项目成果

ANNE E CRESS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad objective of this conference is to bring together basic and clinical scientists to discuss new therapeutic targeting strategies for eradicating or preventing prostate cancer. The goal is to accelerate both the pace of discovery of new knowledge in the prevention, detection, diagnosis and treatment of prostate cancer and the translation of these discoveries into practical applications. Prostate cancer is the second leading cause of death of men in the United States. Prostate cancer has unique features not shared by other epithelial malignancies. Currently new advances have been made in understanding molecular progression event in the disease and clinically relevant insights exist. However, there are few examples of new therapies to treat prostate cancer. The goal of this meeting is to provide a forum for the exchange of new information and ideas concerning the molecular basis for prostate cancer development and stimulate translational research to solve clinically relevant problems in the disease. This meeting is structured such that within each session presentations are given on clinically relevant features and the molecular cellular biology or genetic aspect of the disease. In particular, sessions will emphasize alterations in the extracellular matrix and their receptors, stromal-epithelial interactions, genetic risk factors, early targeting for chemoprevention and imaging of the prostate gland. This is an inaugural meeting that is important for two reasons. It provides a forum for the interaction of clinicians and scientists to examine particular discoveries in prostate cancer biology within the context of clinically relevant issues. The meeting also will serve as an interface for the development of novel therapeutic strategies based upon the basic biology of the prostate gland. It is anticipated that the exchange of information and ideas through a highly interactive meeting will help generate new concepts and ideas that will have an impact on prostate cancer prevention and cure.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting of prostate cancer.
前列腺癌的治疗靶向。
DOI: 10.4161/cbt.3.10.1266
发表时间: 2004
期刊: Cancer biology & therapy
影响因子: 3.6
作者: [Cress,AnneE, Mohla,Suresh]
通讯作者: Mohla,Suresh
Centrosome instability as a mechanism to promote localized prostate cancer
  • 批准号:
    10226121
  • 项目类别:
  • 资助金额:
    $55.8万
  • 财政年份:
    2019
  • 负责人:
    ANNE E CRESS
  • 依托单位:
Centrosome instability as a mechanism to promote localized prostate cancer
  • 批准号:
    10453728
  • 项目类别:
  • 资助金额:
    $54.68万
  • 财政年份:
    2019
  • 负责人:
    ANNE E CRESS
  • 依托单位:
Centrosome instability as a mechanism to promote localized prostate cancer
  • 批准号:
    9815223
  • 项目类别:
  • 资助金额:
    $55.8万
  • 财政年份:
    2019
  • 负责人:
    ANNE E CRESS
  • 依托单位:
Centrosome instability as a mechanism to promote localized prostate cancer
  • 批准号:
    10664978
  • 项目类别:
  • 资助金额:
    $58.57万
  • 财政年份:
    2019
  • 负责人:
    ANNE E CRESS
  • 依托单位:
海外基金